dijous, 6 de febrer del 2014

Diabetes: DexCom lands FDA approval for pediatric continuous glucose monitor




The DexCom G4 Platinum is now available for diabetic children ages 2 to 17.





Diabetes: DexCom lands FDA approval for continuous glucose monitor

(NSDQ:DXCM) said it secured FDA approval for its DexCom G4 Platinum continuous glucose monitor for diabetic children ages 2 to 17.


News Well, Diabetes, Patient Monitoring, Regulatory/Compliance

read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1cZiIj6
Publicat per a
Etiquetes de comentaris: ,

Cap comentari:

Publica un comentari a l'entrada

Subscriure's a: Comentaris del missatge (Atom)